Ftse Mib
35.171,11
1,02%
DAX
18.716,42
-0,12%
S&P 500
5.222,26
0,02%
NASDAQ
16.428,07
0,24%
Bitcoin
61.689,13
-1,93%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Puma Biotechnology Inc (PBYI) Puma Biotechnology Inc (PBYI) Notizie

Puma Biotechnology Inc

PBYI
5,1188
-0,0162 (-0,32%)
Ultimo aggiornamento: 17:45:33
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202422:05BWPuma Biotechnology Reports First Quarter Financial Results
18/4/202422:15BWPuma Biotechnology to Host Conference Call to Discuss First..
03/4/202423:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
20/3/202413:30BWPuma Biotechnology Announces FDA Allowance to Proceed Under..
29/2/202422:16EDGAR2Form 8-K - Current report
29/2/202422:05BWPuma Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202400:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
22/2/202422:10BWPuma Biotechnology to Participate in a Panel Discussion at..
15/2/202422:10BWPuma Biotechnology to Host Conference Call to Discuss Fourth..
15/2/202400:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202414:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202414:30BWPuma Biotechnology Announces Initiation of ALISCA-Lung1..
06/2/202421:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202415:00EDGAR2Form 8-K - Current report
11/1/202422:07BWPuma Biotechnology to Present at B. Riley Securities 4th..
10/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:38EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
06/1/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:40EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:39EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:35EDGAR2Form 144 - Report of proposed sale of securities
04/1/202403:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202314:30BWPuma Biotechnology Announces Phase II Clinical Trial Design..
06/11/202323:15BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
02/11/202321:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:19EDGAR2Form 8-K - Current report
02/11/202321:05BWPuma Biotechnology Reports Third Quarter 2023 Financial..
19/10/202322:14BWPuma Biotechnology to Host Conference Call to Discuss Third..
14/10/202318:30BWPuma Biotechnology Announces Presentation of Findings from a..
04/10/202323:30BWPuma Biotechnology Reports Inducement Awards Under Nasdaq..
26/9/202322:10EDGAR2Form 8-K - Current report
21/9/202323:02DJNPuma Biotechnology Stock Up 6.9% on New FDA Orphan Drug..
21/9/202322:55DJNPuma Biotechnology Gets Orphan Designation for Small Cell..
21/9/202322:10BWPuma Biotechnology Receives FDA Orphan Drug Designation for..
01/9/202316:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/8/202322:07BWPuma Biotechnology to Present at the H.C. Wainwright 25th..
18/8/202322:17EDGAR2Form 8-K - Current report
08/8/202314:30BWPuma Biotechnology Announces FDA Clearance of IND for..
03/8/202322:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:12EDGAR2Form 8-K - Current report
03/8/202322:05BWPuma Biotechnology Reports Second Quarter Financial Results
20/7/202322:15BWPuma Biotechnology to Host Conference Call to Discuss Second..
07/7/202301:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202301:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 5,12 Min: 5,00 Max: 5,20
Chiusura: 5,135

La tua Cronologia

NASDAQ
PBYI
Puma Biotechnology
NASDAQ
SAL
Salisbury Bancorp
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network